Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Bovine respiratory syncytial virus, live, Bovine parainfluenza virus 3 attenuated
Merial Animal Health Limited
QI02AD07
Bovine respiratory syncytial virus, live, Bovine parainfluenza virus 3 attenuated
.
Nasal spray, lyophilisate and solvent for suspension
POM (E): Prescription Only Exempt as defined in relevant national legislation
Cattle
bovine respiratory syncytial virus + bovine parainfluenza virus
Immunological - Live Vaccine
Authorised
2018-04-13
Health Products Regulatory Authority 19 April 2018 CRN000W73 Page 1 of 5 1 NAME OF THE VETERINARY MEDICINAL PRODUCT BOVALTO RESPI INTRANASAL, nasal spray, lyophilisate and solvent for suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (2 ml) contains: LYOPHILISATE: ACTIVE SUBSTANCES: Bovine parainfluenza 3 virus (PI3V), modified live virus, strain Bio 23/A 10 5.0 – 10 7.5 TCID 50 Bovine respiratory syncytial virus (BRSV), modified live virus, strain Bio 24/A 10 4.0 – 10 6.0 TCID 50 TCID 50 – a 50% infectious dose for tissue cultures SOLVENT: Phosphate buffered saline 2 ml For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Nasal spray, lyophilisate and solvent for suspension Appearance before reconstitution: The lyophilisate has a porous structure, off-white or yellowish colour. The solvent is clear, colourless. Appearance after reconstitution: opalescent liquid of yellowish to pinkish colour. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the active immunisation of calves from the age of 10 days against bovine respiratory syncytial virus (BRSV) and bovine parainfluenza 3 virus (PI3V), to reduce the quantity and duration of nasal excretion of both viruses. Onset of immunity: 10 days after vaccination Duration of immunity: 12 weeks after vaccination. Health Products Regulatory Authority 19 April 2018 CRN000W73 Page 2 of 5 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The laboratory efficacy studies have demonstrated that the presence of maternally derived antibodies at the time of vaccination had no impact on vaccine efficacy in young animals. Vaccinate healthy animals only. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Vaccinated calves can excrete the vaccine strains BRSV and PI3V for up to 6 days after vaccination. Therefore, the spread of the vaccine virus from vaccinated to unvaccinated calves cannot be Read the complete document